Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017)
Nephros' (NEPH) quarterly Non-Current Deffered Revenue came in at $208000.0 in Q4 2017, down 25.18% year-on-year from $278000.0 in Q4 2016, and down 7.56% quarter-over-quarter from $225000.0 in Q3 2017.
Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017) Analysis & Trends
Nephros' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $208000.0 for Q4 2017.
- On a quarterly basis, Non-Current Deffered Revenue fell 25.18% year-over-year to $208000.0 in Q4 2017; TTM through Dec 2017 was $208000.0, a 25.18% decrease from a year earlier, with the FY2017 full-year figure at $208000.0, down 25.18% from the prior year.
- Non-Current Deffered Revenue slipped to $208000.0 in Q4 2017 per NEPH's latest filing, from $225000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $531000.0 in Q1 2013 and bottomed at $176000.0 in Q3 2013.
- The 5-year median for Non-Current Deffered Revenue is $338500.0 (2015), against an average of $333833.3.
- Across the five-year window, Non-Current Deffered Revenue plunged 80.02% in 2013 and jumped 146.59% in 2014, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $176000.0 in 2013, then soared by 136.93% to $417000.0 in 2014, then dropped by 16.79% to $347000.0 in 2015, then declined by 19.88% to $278000.0 in 2016, then declined by 25.18% to $208000.0 in 2017.
- Per Business Quant, the three latest NEPH Non-Current Deffered Revenue figures stand at $208000.0 (Q4 2017), $225000.0 (Q3 2017), and $243000.0 (Q2 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 163.15 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 208,000.00 |
| Sep 30, 2017 | 225,000.00 |
| Jun 30, 2017 | 243,000.00 |
| Mar 31, 2017 | 261,000.00 |
| Dec 31, 2016 | 278,000.00 |
| Sep 30, 2016 | 295,000.00 |
| Jun 30, 2016 | 313,000.00 |
| Mar 31, 2016 | 330,000.00 |
| Dec 31, 2015 | 347,000.00 |
| Sep 30, 2015 | 365,000.00 |
| Jun 30, 2015 | 382,000.00 |
| Mar 31, 2015 | 400,000.00 |
| Dec 31, 2014 | 417,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Jun 30, 2014 | 452,000.00 |
| Sep 30, 2013 | 176,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Mar 31, 2013 | 531,000.00 |
| Dec 31, 2012 | 707,000.00 |
| Sep 30, 2012 | 881,000.00 |